Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Double-masked Evaluation of Treatment Duration of the UVX System for Treating Infectious Keratitis

NCT00912509 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.

NCT NCT00912509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00912509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Double-masked Evaluation of Treatment Duration of the UVX System for Treating Infectious Keratitis
Lead sponsor
Price Vision Group
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2009
Completion date
June 30, 2013
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious keratitis